Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Branch Retinal Vein Occlusion with Macular Edema”

53 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 53 results

Large-scale testing (Phase 3)Study completedNCT01198327
What this trial is testing

Extended Follow-up of Patients With Macular Edema Due to Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Peter A Campochiaro, MD 66
Post-approval studies (Phase 4)Study completedNCT01710839
What this trial is testing

Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion

Who this might be right for
Central Retinal, Hemi Retinal & Brach Retinal Vein Occlusions
Charles C Wykoff, PhD, MD 30
Large-scale testing (Phase 3)Study completedNCT04264819
What this trial is testing

Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 295
Post-approval studies (Phase 4)Study completedNCT01027481
What this trial is testing

Ranibizumab in Patients With Branch Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Medical University of Vienna 30
Post-approval studies (Phase 4)Study completedNCT02953938
What this trial is testing

Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety

Who this might be right for
Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)
Novartis Pharmaceuticals 59
Large-scale testing (Phase 3)Ended earlyNCT00500045
What this trial is testing

Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions

Who this might be right for
Central Retinal Vein OcclusionBranch Retinal Vein Occlusion
Palo Alto Medical Foundation 36
Post-approval studies (Phase 4)Study completedNCT01903720
What this trial is testing

A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein Occlusion

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Allergan 71
Post-approval studies (Phase 4)Study completedNCT01085734
What this trial is testing

Single Site, Masked, Randomized, Controlled Study to Assess Efficacy of Osurdex as Adjunct to Avastin Compared With Avastin Alone in the Treatment of Patients With Macular Edema Due to Central or Branch Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusions
Maturi, Raj K., M.D., P.C. 30
Post-approval studies (Phase 4)UnknownNCT03405376
What this trial is testing

Prospective Trial of Treat and Extend Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein Occlusion With Macular Edema
Yeungnam University College of Medicine 49
Post-approval studies (Phase 4)Study completedNCT06708624
What this trial is testing

Ocular Safety and Usability Study for FYB201 PFS

Who this might be right for
Age-Related Macular DegenerationBranch Retinal Vein Occlusion with Macular EdemaCentral Retinal Vein Occlusion with Macular Edema
Formycon AG 31
Testing effectiveness (Phase 2)Study completedNCT04667897
What this trial is testing

601 Versus Ranibizumab in Patients With Branch Retinal Vein Occlusion (BRVO)

Who this might be right for
Branch Retinal Vein Occlusion
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 60
Testing effectiveness (Phase 2)UnknownNCT01809236
What this trial is testing

Efficacy and Safety of Conbercept in Macular Edema Secondary to Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Chengdu Kanghong Biotech Co., Ltd. 60
Large-scale testing (Phase 3)Study completedNCT01976338
What this trial is testing

Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO)

Who this might be right for
Macular Edema Secondary to Branch Retinal Vein Occlusion
Novartis Pharmaceuticals 283
Large-scale testing (Phase 3)Study completedNCT01512901
What this trial is testing

Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI)

Who this might be right for
Macular Edema Following Branch Retinal Vein Occlusion
Santen Pharmaceutical Co., Ltd.
Large-scale testing (Phase 3)Study completedNCT02698566
What this trial is testing

A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS)

Who this might be right for
Macular Edema
Genentech, Inc. 35
Not applicableStudy completedNCT03054766
What this trial is testing

Combination of Intravitreal Ranibizumab With or Without Macular Laser Photocoagulation for ME Secondary to BRVO

Who this might be right for
Branch Retinal Vein OcclusionRanibizumabLaser Photocoagulation
Beijing Hospital 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT06664502
What this trial is testing

A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-finding Safety and Preliminary Efficacy Study in Participants With Either Diabetic Macular Edema or Neovascular Age-related Macular Degeneration

Who this might be right for
Diabetic Macular Edema (DME)Neovascular Age-related Macular Degeneration (NVAMD)BRVO - Branch Retinal Vein Occlusion
EyeBiotech Ltd. 38
Testing effectiveness (Phase 2)Study completedNCT07550504
What this trial is testing

Evaluate the Usability of the SB11 PFS in Trial Participants With Wet AMD, Macular Oedema Secondary to RVO, or mCNV

Who this might be right for
Age-Related Macular DegenerationBranch Retinal Vein Occlusion With Macular EdemaCentral Retinal Vein Occlusion With Macular Edema+1 more
Samsung Bioepis Co., Ltd. 30
Large-scale testing (Phase 3)Study completedNCT01377597
What this trial is testing

Efficacy and Safety of Ranibizumab in Japanese Patients With Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Novartis Pharmaceuticals 47
Testing effectiveness (Phase 2)Study completedNCT02006147
What this trial is testing

Phase 1 Open-label Study to Evaluate Efficacy and Tolerability of TLC399 in Patients With Macular Edema Due to RVO

Who this might be right for
Central Retinal Vein Occlusion With Macular EdemaBranch Retinal Vein Occlusion With Macular Edema
Taiwan Liposome Company 14
Load More Results